CI-1040 2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺
CAS 212631-79-3 MFCD02683961
化学结构图
SMILES: O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl
化学属性
| Mol. Formula | C17H14ClF2IN2O2 |
|---|---|
| Mol. Weight | 478.66 |
| Melting Point | 176.0 to 180.0 deg-C |
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name | CI-1040 |
|---|---|
| CAS Number | 212631-79-3 |
| Synonym | 2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide 2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide CI-1040 2-[(2-Chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamide 3,4-Difluoro-2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxybenzamide CI 1040 CI-1040 CI1040; CI-1040; CI 1040; PD184352; PD 184352; PD-184352. |
| MDL Number | MFCD02683961 |
| PubChem Substance ID | 329823755 |
| Chemical Name Translation | 2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
| Reaxys-RN | 10032343 |
| Formula | C17H14ClF2IN2O2 |
| IUPAC Name | 2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide |
| InChIKey | GFMMXOIFOQCCGU-UHFFFAOYSA-N |
| InChI | InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24) |
| Canonical SMILES | O=C(NOCC1CC1)C2=CC=C(F)C(F)=C2NC3=CC=C(I)C=C3Cl |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Kinase/Phosphatase Biology, Mitogen-Activated Protein Kinase Kinase (MAPKK), P-PH, Pfizer Compounds, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Approved Therapeutics/Drug C
产品应用
- CI-1040, also known as PD184352, is a MEK inhibitor, which demonstrated in vivo activity in preclinical animal models and subsequently became the first MEK inhibitor to enter clinical trial. CI-1040 suffered however from poor exposure due to its poor solubility and rapid clearance, and as a result, development of the compound was terminated.
相关文献及参考
- Adeyinka, A., et al.: Clin. Cancer Res., 8, 1747 (2002),
- Watanabe K., et al., Blockade of the extracellular signal-regulated kinase pathway enhances the therapeutic efficacy of microtubule-destabilizing agents in human tumor xenograft models. Clin. Cancer Res. 16 , 1170-1178, (2010) 摘要
- Kiyonari H., et al., Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability. Genesis 48 , 317-327, (2010) 摘要
- Mattingly R.R.,, The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines. J. Pharmacol. Exp. Ther. 316 , 456-465, (2006) 摘要
安全信息
GHS Symbol
- P273 Avoid release to the environment. 避免释放到环境中。
- H400 Verytoxictoaquaticlife 对水生生物毒性非常大。
- S60 This material and its container must be disposed of as hazardous waste 该物质及其容器必须作为危险废物处置；
- S61 Avoid release to the environment. Refer to special instructions/safety data sheet 避免释放到环境中，参考特别指示/安全收据说明书；
- R50/53
